| Keizman D, Maimon N, Ish-Shalom M, et al.
An animal model for chemotherapy-associated steatohepatitis and its prevention by the oral administration of fatty acid bile acid conjugate. [JOURNAL ARTICLE]
Cancer 2009 Nov 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Nishiyama M, Wada S
Docetaxel: its role in current and future treatments for advanced gastric cancer. [Journal Article]
Gastric Cancer 2009; 12(3):132-41.
Abstract | Full Citation |
| Bhargava A, Vaishampayan UN
Satraplatin: leading the new generation of oral platinum agents. [Journal Article]
Expert Opin Investig Drugs 2009 Nov; 18(11):1787-97.
Abstract | Full Citation |
| Goerner M, Riemer-Hommel P
Economic impact of alternative adjuvant chemotherapy regimens for stage III colon cancer. [Journal Article]
Onkologie 2009 Nov; 32(11):647-52.
Abstract | Full Citation |
| Ramanathan RK, Rothenberg ML, de Gramont A, et al.
Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 3.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Floyd RA, Towner RA, Wu D, et al.
Anti-cancer activity of nitrones in the Apc(Min/+) model of colorectal cancer. [JOURNAL ARTICLE]
Free Radic Res 2009 Nov 3.
Abstract | Full Citation | Find Related Articles |
| Richman SD, Seymour MT, Chambers P, et al.
KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Tesniere A, Schlemmer F, Boige V, et al.
Immunogenic death of colon cancer cells treated with oxaliplatin. [JOURNAL ARTICLE]
Oncogene 2009 Nov 2.
Abstract | Full Citation |
| Cleary JM, Tanabe KT, Lauwers GY, et al.
Hepatic Toxicities Associated with the Use of Preoperative Systemic Therapy in Patients with Metastatic Colorectal Adenocarcinoma to the Liver. [JOURNAL ARTICLE]
Oncologist 2009 Oct 30.
Abstract | Full Citation | Find Related Articles |
| Koizumi W, Takiuchi H, Yamada Y, et al.
Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study). [JOURNAL ARTICLE]
Ann Oncol 2009 Oct 29.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
